You are here

Article Text

Article menu
Download PDFPDF
Editorial commentary
Self-reported health in people with Parkinson’s disease left untreated at diagnosis
  1. Peter Hagell
  1. Correspondence to:
 P Hagell
 Department of Health Sciences, Lund University, PO Box 157, SE-221 00 Lund, Sweden; peter.hagell{at}med.lu.se

https://doi.org/10.1136/jnnp.2006.109454

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Early initiation of treatment in Parkinson’s disease prevents patient-reported deteriorations, but what is gained?

    The paper by Grosset et al1 (see p 465) in this issue describes self-reported health in a “real-life” cohort of dopa-naïve people with Parkinson’s disease (PD). Assessments using the Parkinson’s Disease Questionnaire (PDQ)-39 at initial consultation and for up to 18 months thereafter suggest stable self-reported health among patients who were started on dopaminergic treatment, whereas those who remained dopa-naïve deteriorated.

    These observations add valuable fuel to the discussion on when to start dopaminergic treatment in PD.2,3 However, it remains to be determined whether initial benefits last in the long term, or …

    View Full Text

    Footnotes

    • Published Online First 29 November 2006

    • Competing interests: None.

    Linked Articles